FormBlends Review: What We Could and Could Not Verify
This review is shorter than our others, and that is the finding. We could not independently verify FormBlends' pricing, and the company's own pages quote two different numbers. Here is what we found and how to evaluate it yourself.
Last updated: August 3, 2026
Quick Verdict
FormBlends offers compounded semaglutide and tirzepatide, and we could not pin down what it costs. On its own comparison pages the company quotes compounded semaglutide starting at $297/month in one place and $199/month with a free physician consultation in another. Both figures are self-published.
Independent coverage is thin. Almost everything we found about FormBlends was published by FormBlends - a large library of comparison articles on its own domain covering competitors, pricing and category questions. We found no substantive third-party review, no aggregator rating, and no mainstream coverage of the kind that exists for Fridays or the larger providers.
To be clear about what this is and is not: a content marketing operation is not evidence of wrongdoing, and plenty of legitimate companies build one. But it means you cannot check the company's claims against anyone else's, and that changes how carefully you should verify things yourself before paying.
The Conflicting Price Figures
| Claim | Price | Source |
|---|---|---|
| Compounded semaglutide | Starting at $297/month | Company comparison page |
| Compounded semaglutide | $199/month, free physician consult | Different company page |
| Cheapest in category | $145/month | Company article, referring to the market |
There are innocent explanations for a $199/$297 gap - different plan lengths, different doses, promotional pricing on one page and standard pricing on another, or simply a page that has not been updated. Pricing pages go stale constantly in this category.
The practical consequence is the same regardless of the explanation: you cannot budget from a published figure here. Get a written quote for your specific medication, dose and plan length before providing payment details - and specifically ask whether the price changes as you titrate.
Category Benchmarks to Judge Against
Whatever quote you receive, here is the market it sits in:
| Medication | Typical Compounded Range | Aggressive End |
|---|---|---|
| Compounded semaglutide | $150-$300/month | $99-$117 on annual plans |
| Compounded tirzepatide | $250-$450/month | $125 on annual plans |
| Brand Ozempic tablets | $149 starter / $299 maintenance | FDA-approved |
Against that: $297 for compounded semaglutide sits at the top of the normal range, and is more than double what Trimi charges on its annual plan. $199 is mid-range and competitive but not exceptional. Neither figure is out of line with the market - but neither is a bargain, which matters because price is the main reason to choose a compounded provider over an FDA-approved product in the first place.
Worth sitting with: at $297/month for compounded semaglutide, you are paying roughly the same as $299/month for brand-name Ozempic tablets at a maintenance dose - an FDA-approved product with an established manufacturing standard. If a compounded price approaches the brand-name price, the main argument for compounding has disappeared. See our Ozempic pill cost guide.
Why Self-Published Comparisons Need Care
FormBlends publishes an extensive set of comparison articles - head-to-heads against named competitors, "cheapest provider" roundups, category explainers. These rank well and are often the first result for the queries they target.
We run affiliate content ourselves and disclose it, so this is not a criticism of the format. But it is worth stating plainly how to read it:
- A company's comparison of itself against competitors is marketing, however even-handed the tone. The selection of which competitors appear, which attributes get compared, and which prices are quoted all sit with the interested party.
- Competitor prices in such articles may be stale or unfavourably framed. Verify any competitor figure at the competitor's own site before acting on it.
- Ranking first is not third-party validation. It reflects SEO investment, which is orthogonal to clinical quality.
The signal we would actually want - and could not find - is independent verification: aggregator ratings with meaningful volume, mainstream press coverage, or a substantial base of reviews on a platform the company does not control. Fridays has a 4.5 Trustpilot score across 4,000+ reviews plus US News and USA Today coverage; Trimi has a smaller but real 3.8 across 62 reviews. We found no comparable data point for FormBlends.
The Compounding Caveat
This applies to the entire compounded category, FormBlends included:
- The FDA resolved the tirzepatide shortage in December 2024 and the semaglutide injection shortage in February 2025, establishing phased enforcement policies for compounders.
- It has since proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, finding no clinical need for outsourcing facilities to compound them.
- Compounded medications are not FDA-approved and are not evaluated by the FDA for safety, effectiveness or quality.
The narrower the price advantage over an FDA-approved product, the harder this trade-off is to justify. Our full guide to the FDA status of compounded GLP-1s covers the complete timeline, and our compounded semaglutide guide covers what to ask about sourcing, testing and licensure.
How to Evaluate Any Unverifiable Provider
This checklist applies to FormBlends and to every small provider you cannot check from outside. None of these questions are unreasonable, and a provider's willingness to answer them is itself information.
- Get a written quote for your medication, your dose and your plan length - before providing payment details.
- Ask which compounding pharmacy fills your prescription, whether it is 503A or 503B, and what state it is licensed in. Then verify that licence with the state board yourself.
- Ask for third-party potency and sterility testing for the specific formulation you would receive.
- Ask whether the price changes as you titrate. Dose-tiered pricing is common and is the most frequent cost surprise in this category.
- Get the cancellation and refund terms in writing, including what happens if compounded medication becomes unavailable mid-term.
- Confirm the prescriber is licensed in your state and that you can reach them with questions after you start.
- Search for reviews on platforms the company does not control - and treat a near-total absence as a reason to go slowly, not as a clean record.
Our recommendation on FormBlends specifically: we are not telling you to avoid it - we have no evidence of anything wrong. We are saying the outside information needed to recommend it does not exist yet. If the quote you receive is competitive and the questions above are answered clearly, that is a reasonable basis to proceed. Start month-to-month rather than prepaying.
Frequently Asked Questions
How much does FormBlends cost?
We could not establish a single answer. The company quotes compounded semaglutide starting at $297/month on one of its comparison pages and $199/month with a free physician consultation on another. Both are self-published and we found no independent source to check them against. Get a written quote for your specific medication, dose and plan length before paying.
Is FormBlends legitimate?
We found no evidence of wrongdoing, and nothing here should be read as an allegation. What we did find is an absence: no substantive third-party review, no aggregator rating, no mainstream coverage. That is not the same as a bad record - it means there is no outside information to check the company's claims against, so you need to verify more yourself than you would with a provider that has thousands of independent reviews.
Is $297 a good price for compounded semaglutide?
No - it sits at the top of the typical $150-$300 range, and more than double what Trimi charges on its annual plan. More pointedly, it is roughly what brand-name Ozempic tablets cost at a maintenance dose ($299), and that is an FDA-approved product. When a compounded price approaches the brand-name price, the main reason to choose compounding has gone.
Why does this review rate it 3 out of 5 provisionally?
Because the rating reflects what we could verify, not a judgment about the company. We have no negative findings and no positive independent signals either. If credible third-party data emerges - aggregator ratings with volume, press coverage, or a substantial review base - we will revisit it in either direction.
Can I trust a provider's own comparison articles?
Read them as marketing, however even-handed the tone. The company chooses which competitors appear, which attributes are compared, and which prices are quoted - and competitor figures may be stale or unfavourably framed. Always verify a competitor's price at that competitor's own site. Ranking first in search reflects SEO investment, not clinical quality.
What should I ask before signing up anywhere?
Which compounding pharmacy fills your prescription and its state licence (then verify it with the state board yourself), whether third-party potency and sterility testing exists for your formulation, whether the price changes as you titrate, the cancellation and refund terms in writing, and whether your prescriber is licensed in your state and reachable after you start.
Which budget provider has the best independent evidence?
Of the ones we reviewed, Fridays - a 4.5 Trustpilot score across more than 4,000 reviews plus US News and USA Today coverage. Trimi has a smaller but real signal at 3.8 across 62 reviews and considerably cheaper tirzepatide. Both carry the same category-level compounding caveat.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. HealthyPound is not affiliated with FormBlends. This review reports what we were and were not able to verify from publicly available sources at the time of writing; the absence of independent coverage is not an allegation of wrongdoing, and no negative findings are asserted. Pricing figures are drawn from the company's own published pages and change frequently - verify current pricing and terms directly with the provider. Compounded medications are not FDA-approved and are not evaluated by the FDA for safety, effectiveness or quality; the regulatory status of compounded semaglutide and tirzepatide is subject to ongoing FDA action. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. HealthyPound may receive compensation from affiliate partners mentioned in this article. See our affiliate disclosure and full medical disclaimer.